Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets - PharmaTher Holdings (OTC:PHRRF), Field Trip Health (OTC:FTHWF) : vimarsana.com

Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.

Related Keywords

Irvine , California , United States , Washington , Australia , Chicago , Illinois , Israel , Reunion , New York , Mujeeb Jafferi , Eugene Lipov , Amardeep Manhas , Operation Forces Protocol , Pharmather Holdings Ltd , Vitruvias Therapeutics Inc , Abbreviated New Drug Application , Field Trip , Reunion Neuroscience , Dual Sympathetic Reset , Stellate Ganglion Block , Post Traumatic Stress Injury , Special Operation Forces Protocol ,